WHAT WE DO
We envision a vibrant ecosystem by building a global life science ecosystem from biotechnology tools to venture creation
Life Science Tools
We are a growth stage business with a market access platform in more than 100 countries. We have established major call points with academic labs and the biopharma industries, which is synergistic with Esco Ventures tech scouting. Our novel life sciences tools lead to potential data plays.
Esco Medical provides fertility technologies and is our growth star business, with call point synergies with our Life Sciences Tools business.
We collaborate with academic labs and focus on ventures creation to address rare and Asian prevalent diseases. The establishment of Esco Ventures X, Carmine Therapeutics and the Fellowship program allows access and development of talent and platform technologies in Singapore to the US and China.
Precision Medicine Diagnostics
Carmentix is developing a diagnostic kit to predict preterm birth, with potential call point synergies with Esco Medical. We develop and invest in novel life sciences tools and diagnostic platforms.
Bioprocessing Tools & Services
Spearheaded by Esco Aster CDMO, we leverage synergies with our life sciences tools and biotech venture businesses, exposing ourselves to the fast growing cell & gene therapy market.
GLOBAL LIFE SCIENCES ECOSYSTEM
With a presence in more than 100 countries, we seek to build a global life science ecosystem
Building Life Sciences Ecosystems
At Esco, we strive to create life sciences ecosystems that will help connect the world to Southeast Asia, and Southeast Asia to the world.
Rapid Growing Economy
Southeast Asia is the 7th largest economy in the world and is rapidly growing. The region is a hotbed for healthcare innovation and investment as it has the 3rd largest labor force in the world, with a population of 600 million and an annual GDP of US$2.3 trillion. It is also predicted to become the 4th largest single market after the US, EU and China by 2030
Esco Lifesciences Group has established a presence in China since the 1990s
Esco Taicang Innovation Center
In 2018, Esco Lifesciences Group announced an investment of RMB100 million to build a 20,000m2 Innovation Center in Taicang, Suzhou, in Jiangsu province. The new facility will accelerate commercialization of life sciences, medical devices, reproductive medicine and precision medicine technologies. It is located just 50km from central Shanghai.
The completion of the facility in 2019 will see Esco accelerate investments in local R&D, collaborations with academic institutions, and in-licensing/joint ventures with global startups to commercialize their technologies in China.
In 2005, Esco Technologies was incorporated in Philadelphia to seek new technologies. In addition, Esco Biotech Inc was established in Houston to sell Esco Lab products, which then merged into a new facility in Hatboro, PA two years later. In 2012, the Pharma and Medical divisions were established, with Pharma having a factory in Feasterville, PA.
With sales growth accelerating, the company relocated into a much larger premise in Horsham in 2015 — a move that enabled an extensive expansion of our sales network throughout the US and Canada, making Esco Technologies a one-stop shop and key player for Life Sciences, Medical and Pharma in North America.
In 2018, Esco Ventures established an office at the Cambridge Innovation Center in Cambridge, Massachusetts.
Esco has offices in the UK, Germany, Italy, and Russia, with factories in the UK and Lithuania.
Esco Medical Technologies UAB
We have recently acquired AT Medical UAB, an Esco Ventures portfolio company, to accelerate development of the Esco life sciences ecosystem and delivery of innovative fertility technologies. AT Medical UAB, renamed as Esco Medical Technologies UAB, continues operations as a separate legal entity within the Esco Group’s life science ecosystem.
Esco Gb Ltd
Esco Technologies S.r.l.